Filter by Event: ESCMID Global 2026
Activity of Aztreonam-Avibactam and Comparators against Difficult-to- Treat Resistant (DTR) Enterobacterales from Patients with Pneumonia or Intra-abdominal Infections (IAI) in European Medical Centers (2020-2024)
Activity of Aztreonam-Avibactam and Comparators against Difficult-to- Treat Resistant (DTR) Enterobacterales from Patients with Pneumonia or Intra-abdominal Infections (IAI) in European Medical Centers (2020-2024). Lead author: Helio S. Sader, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #1273
Activity of Zosurabalpin Against Carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRABC) Isolates Producing NDM and/or Oxacillinase Enzymes
Activity of Zosurabalpin Against Carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRABC) Isolates Producing NDM and/or Oxacillinase Enzymes. Lead author: Mariana Castanheira, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #1351
Activity of manogepix against invasive fungal infections from immunocompromised hosts
Activity of manogepix against invasive fungal infections from immunocompromised hosts. Lead author: Marisa L. Winkler, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #3309
Activity of mold-active azole agents against Aspergillus fumigatus clinical isolates nonwildtype to azoles and isolates displaying CYP51 alterations
Activity of mold-active azole agents against Aspergillus fumigatus clinical isolates nonwildtype to azoles and isolates displaying CYP51 alterations. Lead author: Mariana Castanheira, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #3323
Activity of Manogepix and Comparator Antifungals Against Mould Isolates Collected from Invasive Infections in Intensive Care Units (ICU) and Non-ICU Settings (2017–2024)
Activity of Manogepix and Comparator Antifungals Against Mould Isolates Collected from Invasive Infections in Intensive Care Units (ICU) and Non-ICU Settings (2017–2024). Lead author: Michael Huband, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #3320
Characterization of Candida auris (Candidozyma auris) from a worldwide surveillance program over 12 years
Characterization of Candida auris (Candidozyma auris) from a worldwide surveillance program over 12 years. Lead author: Marisa L. Winkler, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #3305
Activity of Manogepix and Comparator Antifungal Agents Against Yeast Isolates Collected from Invasive Infections in Intensive Care Unit (ICU) and Non-ICU Settings
Activity of Manogepix and Comparator Antifungal Agents Against Yeast Isolates Collected from Invasive Infections in Intensive Care Unit (ICU) and Non-ICU Settings. Lead author: Mariana Castanheira, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #3310
Occurrences by Region and Age Groups and Antifungal Susceptibility Profiles of Opportunistic Filamentous Fungal Pathogens Collected in 8 Years of Global Surveillance
Occurrences by Region and Age Groups and Antifungal Susceptibility Profiles of Opportunistic Filamentous Fungal Pathogens Collected in 8 Years of Global Surveillance. Lead author: Mariana Castanheira, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #3323
Isavuconazole activity against moulds in ICU and non-ICU infections
Isavuconazole activity against moulds in ICU and non-ICU infections. Lead author: SJ Ryan Arends, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #3303
Comparison of manogepix activity against 2,659 community-acquired and nosocomial mould isolates from the SENTRY Antimicrobial Surveillance Program (2017–2024)
Comparison of manogepix activity against 2,659 community-acquired and nosocomial mould isolates from the SENTRY Antimicrobial Surveillance Program (2017–2024). Lead author: Michael Huband, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #3309
Lefamulin Activity against Bacterial Pathogens Typically Causing Community-Acquired Pneumonia Collected from European Medical Centres in 2023 and 2024
Lefamulin Activity against Bacterial Pathogens Typically Causing Community-Acquired Pneumonia Collected from European Medical Centres in 2023 and 2024. Lead author: Helio S. Sader, presented at ESCMID Global 2026, April 20, Munich, Germany
P #1245
Activity of rezafungin against Aspergillus spp.
Activity of rezafungin against Aspergillus spp. Lead author: Marisa L. Winkler, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #3304
Isavuconazole activity against moulds in nosocomial and community-acquired infections
Isavuconazole activity against moulds in nosocomial and community-acquired infections. Lead author: SJ Ryan Arends, presented at ESCMID Global 2026, April 20, Munich, Germany
Poster #3312
Activity of tebipenem against Enterobacterales, including molecularly characterized isolates causing urinary tract and bloodstream infections in the United States and United Kingdom in 2023-2024
Activity of tebipenem against Enterobacterales, including molecularly characterized isolates causing urinary tract and bloodstream infections in the United States and United Kingdom in 2023-2024. Lead author: Timothy Doyle, presented at ESCMID Global 2026, April 19, Munich, Germany
Poster #2644
